Medipharm Labs Corp MEDIF said it applied to upgrade its stock to the Toronto Stock Exchange from the TSX Venture Exchange.
MediPharm is a global extraction, distillation, purification and cannabinoid isolation company. For the last quarter, it reported revenue of $22 million, up by 115% on the year.
Companies listed on larger exchanges are subject to stricter regulations and more scrutiny. It's also easier to attract investors.
Need more cannabis news? Check out all of our coverage here.
With the legalization of cannabis in the U.S. and Canada, more and more companies are feeling confident enough to apply to have their stock listed on a major exchange such as the Toronto Stock Exchange in Canada, or NYSE or NASDAQ in the U.S.
The listing is subject to approval of the Toronto Stock Exchange.
Related Links:
MediPharm Labs Australia Awarded Cannabis Manufacturing License
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.